Related Experiment Video
Updated: Aug 11, 2026

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
Published on: May 11, 2021
Challenges facing drug discovery in vascular disease
Phillip Cowley1, Jason Witherington
1Organon Research, Newhouse, Scotland.
This symposium focused on challenges in drug discovery for vascular diseases like atherosclerosis and stroke. Experts reviewed current and emerging treatments and monitoring technologies for patient risk and disease progression.
Area of Science:
- Pharmacology and Therapeutics
- Cardiovascular Research
- Drug Development
Background:
- Vascular diseases, including atherosclerosis and stroke, pose significant health challenges.
- Effective therapeutic strategies and monitoring technologies are crucial for managing these conditions.
- The pharmaceutical industry and academia are actively seeking novel approaches to combat vascular diseases.
Purpose of the Study:
- To review current and emerging therapeutic strategies for vascular diseases.
- To discuss advancements in technologies for monitoring risk and disease progression.
- To foster collaboration between academia and industry in drug discovery for vascular conditions.
Main Methods:
- Symposium format with international experts from academia and industry.
- Presentations and discussions on atherosclerosis and stroke.
- Review of existing and novel treatment modalities.
- Exploration of technological advancements in patient monitoring.
Main Results:
- Identified key challenges in drug discovery for vascular diseases.
- Highlighted promising therapeutic targets and approaches.
- Emphasized the need for improved technologies for risk assessment and disease monitoring.
- Facilitated knowledge exchange between researchers and industry professionals.
Conclusions:
- Continued innovation in drug discovery is essential for treating vascular diseases.
- Advancements in monitoring technologies can improve patient outcomes.
- Collaborative efforts are vital to accelerate the development of effective vascular disease therapies.
Related Concept Videos
Drug Discovery: Overview
Pharmacogenomics: Identification of New Drug Targets
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Factors Affecting Drug Distribution: Physiological Barriers
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...

